[ACRV] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
30-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -54.35%
YoY- -299.32%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -13,914 -12,756 -8,929 -9,198 -5,820 -7,220 -4,343 117.78%
Tax 7 -1,637 -1,016 -377 -105 8 73 -79.13%
NP -13,914 -11,119 -7,913 -8,821 -5,715 -7,228 -4,416 115.37%
Tax Rate - - - - - - - -
Total Cost 13,914 11,119 7,913 8,821 5,715 7,228 4,416 115.37%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.63 -0.51 -0.38 -0.47 -0.44 -0.56 -0.34 51.03%
EPS Diluted -0.63 -0.51 -0.38 -0.47 -0.44 -0.56 -0.34 51.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.